Covered recipient · General Payments record
ALICE MARIE ORMSBY
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,390.25
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $429.03 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $153.12 | 10 |
| Regeneron Healthcare Solutions, Inc. | $124.99 | 1 |
| Lilly USA, LLC | $59.70 | 2 |
| Dermavant Sciences, Inc. | $41.75 | 2 |
| E.R. Squibb & Sons, L.L.C. | $33.75 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.40 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157897 | CMS |
| ABBVIE INC. | $9.82 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157899 | CMS |
| ABBVIE INC. | $21.48 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157901 | CMS |
| ABBVIE INC. | $19.76 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157903 | CMS |
| ABBVIE INC. | $7.41 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157905 | CMS |
| ABBVIE INC. | $30.99 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157907 | CMS |
| ABBVIE INC. | $7.24 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157909 | CMS |
| ABBVIE INC. | $1.24 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157911 | CMS |
| ABBVIE INC. | $30.59 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157913 | CMS |
| ABBVIE INC. | $10.19 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105157915 | CMS |
| Dermavant Sciences, Inc. | $21.46 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127914731 | CMS |
| Dermavant Sciences, Inc. | $20.29 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127914735 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.80 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101533814 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.95 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101533898 | CMS |
| Lilly USA, LLC | $30.44 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136023023 | CMS |
| Lilly USA, LLC | $29.26 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136015937 | CMS |
| Regeneron Healthcare Solutions, Inc. | $124.99 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114128088 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.72 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152122570 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.